Question

A 57-year-old with type 2 diabetes and established ASCVD (prior MI) has A1C 7.6% on metformin. eGFR 65. What glucose-lowering add-on is preferred for cardiovascular benefit?

Accepted Answer

Sulfonylurea

Answer

DPP-4 inhibitor

Answer

SGLT2 inhibitor or GLP-1 receptor agonist with proven CV benefit

Answer

Thiazolidinedione

Answer

Basal insulin

Practice question

A 57-year-old with type 2 diabetes and established ASCVD (prior MI) has A1C 7.6% on metformin. eGFR 65. What glucose-lowering add-on is preferred for cardiovascular benefit?